Concert Pharmaceuticals Inc. (CNCE) Tuesday announced net loss of $13.03 million for the second quarter, narrower than net loss of $13.44 million last year. On a per share basis, loss narrowed to $0.58 from $0.60 per share.
from RTT - Earnings http://ift.tt/2vftdxZ
via IFTTT
No comments:
Post a Comment